Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Human Recombinant Transforming Growth Factor α Stimulates Bone Resorption and Inhibits Formation in vitro

Kenneth J. Ibbotson, Jane Harrod, Maxine Gowen, Sharyn D'Souza, Donna D. Smith, Marjorie E. Winkler, Rik Derynck and Gregory R. Mundy
Proceedings of the National Academy of Sciences of the United States of America
Vol. 83, No. 7 (Apr. 1, 1986), pp. 2228-2232
Stable URL: http://www.jstor.org/stable/27173
Page Count: 5
  • Read Online (Free)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Human Recombinant Transforming Growth Factor α  Stimulates Bone Resorption and Inhibits Formation in vitro
Preview not available

Abstract

Human recombinant transforming growth factor α (TGFα ), which binds to the epidermal growth factor (EGF) receptor and causes several biological effects similar to those caused by EGF, was compared with murine EGF for its effects on a number of parameters of bone cell metabolism. TGFα stimulated bone resorption in two organ culture systems, the fetal rat long bone and neonatal mouse calvarial systems. TGFα stimulated bone resorption at concentrations as low as 0.1 ng/ml. TGFα effects on bone resorption in mouse calvariae were inhibited by indomethacin, suggesting that, like EGF, its effects were mediated by prostaglandin synthesis. TGFα had a different time course of action on bone resorption from that of EGF, causing more rapid release of previously incorporated 45Ca from bone cultures, suggesting that TGFα does not function on bone as a simple EGF analogue. TGFα also caused effects on osteoblast function resembling those of EGF. It inhibited alkaline phosphatase activity in cultured rat osteosarcoma cells with the osteoblast phenotype and inhibited collagen synthesis in fetal rat calvaria at concentrations of 1.0 ng/ml. The lowest concentration of TGFα (expressed as nanogram equivalents of EGF per ml) required to produce a response in all of the systems tested was about 1/10th of that needed for EGF to produce a similar effect. These results indicate that TGFα is a potent stimulator of bone resorption and inhibitor of bone formation as assessed by inhibition of collagen synthesis and alkaline phosphatase activity and are consistent with the hypothesis that TGFα may be responsible, at least in part, for the bone resorption associated with some tumors.

Page Thumbnails

  • Thumbnail: Page 
2228
    2228
  • Thumbnail: Page 
2229
    2229
  • Thumbnail: Page 
2230
    2230
  • Thumbnail: Page 
2231
    2231
  • Thumbnail: Page 
2232
    2232